Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin versus enoxaparin for prevention of deep vein thrombosis in tibial shaft fractures
IRCT20200202046344N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, double-blind trial of aspirin and enoxaparin in deep vein thrombosis (DVT) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Incidence of deep vein thrombosis. Started Aug 2020; status: completed.
02
Drugs
aspirinenoxaparin
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on IRCT20200202046344N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200202046344N1.